Press Releases
Press Releases
Researcher Discovers Micro RNA Required for the Growth and Spread of Cancer Children’s Hospital Los Angeles
A previously unreported mechanism for the growth and spread of cancer has been reported by Muller Fabbri, MD, first author on the paper that recently appeared in the early edition of the Proceedings of the National Academy of...
Press Releases
Cytheris announces CYT107 orphan drug designation in Europe for the treatment of Progressive Multifocal Leucoencephalopathy (PML)
Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the European Commission has granted an orphan designation for Cytheris' CYT017, glycosylated recombinant human interleukin-7 (glycosylated r-h-IL7), for the treatment of...
Press Releases
Ohio’s Best Rx Card Now Provides Savings to All Ohioans, Regardless of Income Envision Pharmaceutical Services
Ohio’s Best Rx, a free, state-endorsed prescription drug discount program available to seniors and other qualifying low-income families and individuals since 2004, has expanded and is now available to all Ohio residents, regardless of age or income. ...
Press Releases
PsiOxus Therapeutics Secures £22 Million in Series B Financing to Drive Clinical Development for Oncolytic Vaccine
PsiOxus Therapeutics, Ltd. announced that it has closed a Series B round of equity financing totaling £22 million ($34 million). The round included equal investments from existing investors Imperial Innovations Group (AIM: IVO, ‘Innovations’)...
Press Releases
Catalyst Health Solutions Announces Stockholder Approval of Merger with SXC Health Solutions
Catalyst Health Solutions, Inc. , the fastest growing national pharmacy benefit management (PBM) in the U.S., announced today that at a special meeting of stockholders held this morning, its stockholders approved, among other things, the proposal to adopt...
Press Releases
Sucampo Pharmaceuticals Provides Update on Anticipated Arbitration Decision
Sucampo Pharmaceuticals, Inc.today announced that the International Court of Arbitration, International Chamber of Commerce (ICC) has notified the Company of a change in the anticipated date of the decision related to the Company’s demand for arbitration under the...
Press Releases
Nelson Laboratories Selected by DuPont Protection Technologies to Provide Laboratory Testing for DuPont™ Tyvek® Transition Protocol
Nelson Laboratories (www.nelsonlabs.com) announces it has been selected by DuPont Protection Technologies’ Medical and Pharmaceutical Protection unit (www.medicalpackaging.dupont.com) to provide testing in support of a DuPont™ Tyvek® 1073B and Tyvek® 1059B transition project. As...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read